Overview Time-Effect of Montelukast Protection Status: Completed Trial end date: 2008-08-01 Target enrollment: Participant gender: Summary The aim of this study is to verify MNT time of onset of protection against EIB in asthmatic children by evaluating different time intervals between dosing and challenge, after a single-dose and after three days of once a day MNT administration. Phase: Phase 4 Details Lead Sponsor: Universita di VeronaTreatments: Montelukast